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ABSTRACT
A cDNA clone for the Ya subunit of glutathione transferase from rat liver
was constructed in E.coli. The clone hybridized to Ya and Yc subunit messenger
RNAs. On the basis of experiments involving cell-free translation and hybridization
to the cloned probe, it was shown that prototype inducers of cytochrome P-450
such as phenobarbitone and 3-methylcholanthrene as well as inhibitors such as CoCI2
and 3-amino-1,2,4-triazole enhanced the glutathione transferase (Ya+Yc) messenger
RNA contents in rat liver. A comparative study with the induction of cytochrome
P-450 (b+e) by phenobarbitone revealed that the drug manifested a striking increase
in the nuclear pre-messenger RNAs for the cytochrome at 12 hr, but did not signifi-
cantly affect the same in the case of glutathione transferase (Ya+Yc). 3-Amino-I,
2,4-triazole and CoCI2 blocked the phenobarbitone mediated increase in cytochrome
P-450 (b+e) nuclear pre-messenger RNAs. These compounds did not significantly
affect the glutathione transferase (Ya+Yc) nuclear pre-messenger RNA levels.
The polysomal, poly (A)- containing messenger RNAs for cytochrome P-450 (b+e)
increased by 12-15 fold after phenobarbitone administration, reached a maximum
around 16hr and then decreased sharply. In comparison, the increase in the case
of glutathione transferase (Ya+Yc) mesenger RNAs was sluggish and steady and
a value of 3-4 fold was reached around 24 hr. Run-off transcription rates for
cytochrome P-450 (b+e) increased by nearly 15 fold in 4 hr after phenobarbitone
administration, whereas the increase for glutathione transferase (Ya+Yc) was only
2.0 fold. At 12 hr after the drug administration, the glutathione transferase (Ya+Yc)
transcription rates were near normal. Administration of 3-amino-1,2,4-triazole
and CoCI2 blocked the phenobarbitone-mediated increase in the transcription of
cytochrome P-450 (b+e) messenger RNAs. These compounds at best had only marginal
effects on the transcription of glutathione transferase (Ya+Yc) messenger RNAs.
The half-life of cytochrome P-450 (b+e) messenger RNA was estimated to be 3-4
hr, whereas that for glutathione transferase (Ya+Yc) was found to be 8-9 hr. Admi-
nistration of phenobarbitone enhanced the half-life of glutathione transferase (Ya+Yc)
messenger RNA by nearly two fold. It is suggested that while transcription activa-
tion may play a primary role in the induction of cytochrome P-450 (b+e), the induc-
tion of glutathione transferase (Ya+Yc) may essentially involve stabilization of
the messenger RNAs.
INTRODUCTION
Cytochrome P-450 and glutathione transferase constitute two major protein
constituents of the drug metabolizing system (1,2). The induction of specific species
of cytochrome P-450 in response to drug administration is a well known phenomenon.
For example, phenobarbitone induces predominantly cytochrome P-450 b and e
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species in rat liver, whereas 3-methylcholanthrene induces cytochrome P-450 c
and d species (3-5). It has also been shown that these drugs act at the transcription
level in this regard (6-9). Glutathione transferase represents a family of proteins
consisting of two polypeptides recruited from Ya, Yb and Yc subunits in rat liver.
These protein species can be homo or hetero-dimers and the possible existence
of variants of the Ya, Yb and Yc subunits as well as the presence of additional
new subunits have been recognized (10-13). Prototype inducers such as phenobarbitone
and 3-methylcholanthrene have been reported to induce Ya and Yc subunits, with
Ya being the major subunit induced. In addition, it is known that Ya and Yc have
extensive homologies, but are derived from independent messenger RNAs (14-16).
In terms of the mechanism of action of foreign chemicals in inducing the cyto-
chrome P-450 and glutathione transferase protein families, some interesting questions
arise. In the case of cytochrome P-4 50, prototype drugs such as phenobarbitone
and 3-methylcholanthrene induce distinctly different species at the transcription
level. In the case of glutathione transferase, both the drugs seem to induce the
same subunit species, although induction of additional drug-specific subunit species
may also be involved. At this stage, it is not clear whether a transcription activation
mechanism is responsible for the induction of the glutathione transferase subunits.
Secondly, it has been shown in this laboratory that compounds such as CoCI2 and
3-amino-1,2,4-triazole block cytochrome P-450 gene transcription (9). The effects
of such inhibitors of cytochrome P-450 gene expression on the glutathione transferase
system are not known. It is therefore of interest to examine the mechanism of
induction of glutathione transferase in relation to that of cytochrome P-450, so
that a possible explanation for the diverse effects of chemicals on the two gene
systems can be attempted. In the present study, we have examined the mechanism
of action of some of these chemicals on the expression of the glutathione transferase
gene in rat liver, in relation to that of cytochrome P-450, using specific cloned
cDNA probes.
EXPERIMENTAL PROCEDURES
Treatment of animals:
Male albino rats (1O0g body weight) of the Institute strain were given single intra-
peritoneal injections of phenobarbitone (8mg/1 0Og), 3-methylcholanthrene (4mg/1 0Og),
3-amino-1,2,4-triazole (300mg/O00g), cordycepin (3mg/lOOg), actinomycin D (lOp g/
1OOg) and CoCI2 (6mg/1O0g, subcutaneous), where indicated. In some experiments,
multiple injections of some of the drugs were also given. The animals were killed
by decapitation and livers processed for a variety of experiments.
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Purification of glutathione transferase subunits:
Glutathione transferase species were purified essentially by a combination
of the procedures described by Habig et al (17) and Hayes et al (11). Briefly, the
water extract of the livers was loaded on a DEAE-cellulose column and the escape
was concentrated with ammonium sulphate and then loaded on a CM-Sephadex
column. Four peaks of glutathione transferase activity were eluted using 0-80 mM
NaCI gradient. Each peak was pooled, lyophilized and analyzed by 15% acrylamide-
urea gels (18). In this gel system there was distinct separation of Ya, Yb and Yc
subunits of molecular weights 24K, 27K and 30K respectively with another band
moving faster than Ya. The protein bands were transiently stained opaque with
KCI (19) and then each band was sliced out to elicit antibodies in rabbits. Antibodies
were raised to the Yc subunit as well as a mixture of Ya+Yb+Yc subunits.
Construction of a cDNA clone for glutathione transferase:
A rat liver poly (A)-containing messenger RNA library was constructed in
E.coli (C600) using standard protocols of double stranded cDNA synthesis, GC-
tailing and Pst I cut pBR 322 as vector (20). The poly (A)-containing RNA was
isolated from magnesium precipitated polyribosomes (21) obtained from phenobar-
bitone treated rat livers. 439 tetracycline resistant, ampicillin sensitive clones
were screened with [32P]-cDNA prepared against purified glutathione transferase
messenger RNA. Glutathione transferase messenger RNA was purified by immuno-
binding rat liver polyribosomes with IgG prepared against Ya+Yb+Yc subunits and
isolating the immunobound polyribosomes using Protein A-Sepharose chromatography
(22). Translation of total polyribosomal poly (A)-containing RNA and the purified
messenger RNA in the reticulocyte cell-free translation system (23) revelaed a
50 fold enrichment of the messenger RNA. The colonies lighting up were further
characterized by hybrid selection. The restriction map and partial sequence data
are presented in Fig.l. The clone characterized and used in this study was desig-
nated as pGT 19. A clone covering 2/3 of the cytochrome p-450 e messenger RNA
from the 3' end and designated as pP-450 91 (9) was used as a probe to analyse
cytochrome P-450 (b+e) gene expression.
Quantification of messenger RNA for glutathione transferase and cytochrome P-450:
The translatable messenger RNA activity for glutathione transferase (Ya+Yc)
was assessed using the reticulocyte cell-free system (23). Poly(A)-containing RNA
(8p g), isolated from rat livers given different treatments, was translated in a
total volume of 100 p I in the presence of [35S] methionine. The translated products
*were imunobound to glutathione transferase antibodies. The antigen-antibody com-
plex was isolated using S.aureus cells and analyzed by urea-polyacrylamide gel
(15%) electrophoresis and fluorography (18, 24).
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PstI Ava'I Hinf I PstI Taq I Alu I Sau 3A Pst I
/ \ ~~~~~~~~~~~~~~~50bP
GCTGGAACTTCTCCTCTATOTTGAAGAGTTTGATGCCAGCCTTCTGACCTCTTTCCCTCTGCTGAAGGCC
T TCAAGAGCAGAAC
Fig.l. Restriction map and partial sequence analysis of pGT 19 DNA. The experi-
mental details are given in the text.
Messenger RNA contents for glutathione transferase (Ya+Yc) as well as for
cytochrome P-450 (b+e) were also quantified by hybridization to nick-translated
probes employing dot blot and Northern blot hybridization procedures (25). For
this purpose, poly (A)-containing RNA from polyribosomes as well as total RNA
from nuclei were -used. The isolation of nuclear RNA was by the procedure of
Guertin et al (26). The amounts of radioactivity quantified in the hybrids in these
experiments were found to be proportional to the concentration ranges of RNA
used.
Cell-free nuclear transcription:
This was carried out again by the procedure of Guertin et al (26) and has
been described (9). The RNA transcribed in vitro (107 cpm) in the presence of
[a-32P UTP was hybridized to filters containing pGT 19 or pP 450 91 DNA.
Kinetics of messenger RNA induction and half-life of messenger RNA:
Poly(A)-containing RNA was isolated from control as well as phenobarbitone
treated rat liver polyribosomes at different time intervals and messenger RNA
quantified by dot blot hybridization using nick-translated probes. To measure the
half-lives of cytochrome P-450 (b+e) and glutathione transferase (Ya+Yc) messenger
RNAs, actinomycin D or cordycepin was administered 12 hr (cytochrome P-450
b + e) and 20 hr (glutathione transferase Ya+Yc) respectively after phenobarbitone
administration to block fresh transcription and specific messenger RNAs quantified
by hybridization at different time intervals upto 8hr after the administration of
the inhibitors.
Other procedures
Glutathione transferase enzyme activity was measured using 1-chloro 2,4-
dinitro benzene as substrate (17). The cDNA probes were nick-translated to give
3-5x07cpm/h g DNA. Quantitative values on the dot blots were obtained by pun-
ching out the radioactive spots and measuring radioactivity using 0.5% (w/v) 2,5
2500
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Fig.2. Urea-polyacrylamide (15%) gel analysis of rat liver cytosolic proteins. Cytosol
was isolated from phenobarbitone (lane 1), CoCI 2 (lane 2), control (lane 3),
3-amino-1,2,4-triazole (lane 4) and 3-methylcholanthrene (lane 5) treated
rats. 100l g protein was loaded in each lane and stained with Coomassie
Blue. The arrows indicate the positions of glutathione transferase subunits
and the standard proteins (lane 6). BSA- Bovine Serum Albumin, Ova-Ovalbu-
min, Cyt c-Cytochrome c.
diphenyloxazole in toluene as scintillant. Similarly, where necessary the autoradio-
grams were scanned or the protein gel slices were digested with H202 and the
radioactivity measured using 0.5% (w/v) 2,5 diphenyloxazole in Triton-toluene based
scintillant.
RESULTS
In preliminary studies two injections of phenobarbitone and 3-methylcholanth-
rene administration were found to result in enhanced glutathione transferase enzyme
activity. The polyacrylamide gel electrophoretic analysis of the cytosolic proteins
clearly revealed a distinct increase in the Coomassie Blue stain intensity of the
bands comigrating with the Ya, Yb and Yc subunits of glutathione transferase
under conditions of all the drug treatments. There were individual variations, but
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Fig.3. Effect of drug treatments on the translatable activity of glutathione trans-
ferase messenger RNA. Poly (A)- containing RNA was isolated from livers,
24 hr after the drug injection except in the case Of GoGI2 treatment where
RNA was isolated 12 hr after the injection. g8p g of RNA was translated
in lOQil of the reticulocyte lysate cell-free system and 5 x lOkzpm of total
protein radioacti-vity was used for immunobinding and electrophoretic analysis.
The treatments given were: Lane 1, phenobarbitone; Lane 2, 3-methylcho-
lanthrene; Lane 3, saline (control); Lane 4, CoCJ~; Lane 5, 3-amino-1,2,4-tri-
azole.
the Ya subunit in general showed a maximum response (Fig. 2). It was significant
that the inducers (phenobarbitone and 3-methylcholanthrene) as well as the inhibitors
(3-amino-1,2,4-triazole and CoCI2) of cytochrome P-450 synthesis appeared to
increase the glutathione transferase protein content. We also quantified the trans-
latable messenger RNA activity for the Ya and Yc subunits using the reticulocyte
cell-free system 24hr after a single injection of the drugs except in the case of
CoGl2 where the effects were studied l2hr after the injection. The latter time
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TABLE I
Messenger RNA quantification for glutathione transferase subunits by cell-free
translation and northern blot hybridization.
Treatment Cell-free translation Northern blot hybridization
Ya subunit (cpm) Ya+Yc subunits (cpm)
Control 123 715
Phenobarbitone 372 2563
3-methylcholanthrene 385 2772
CoC12 421 1876
3-A mino-l ,2,4-triazole 417 2473
The quantitative values were derived from data presented in Figs. 3 and 4.
The procedures are described in the text.
period was chosen, since the inhibitory effect of CoCI2 administration on cyto-
chrome P-450 synthesis decreased with time and was much more pronounced at
12hr. There was nearly a 3-4 fold increase in the Ya subunit messenger RNA acti-
vity under all conditions of drug treatments. In addition, CoCI2 treatment resulted
in a significant increase in the messenger RNA activity for Yc subunit as well
(Fig 3, Table 1).
In order to quantify the messenger RNA content and the transcription rates
of the glutathione transferase gene, we constructed a cloned cDNA probe. Clone
pGT 19, on the basis of hybrid selection (data not presented) restriction mapping
and partial sequencing (Fig 1) was characterized to be a Ya subunit clone from
the complete sequencing data provided by Pickett et al (16) and Tu et al (27).
pGT 19 covered nearly 2/3 of the Ya subunit messenger RNA from the 3' end,
having an extensive homology with that of the Yc subunit, and therefore the cloned
DNA would hybridize to Ya and Yc subunit messenger RNAs. Northern blot analysis
of the polyribosomal poly (A)-containing RNA isolated from rats treated with the
different drugs under conditions described in Fig.3 revelaed that a 3-4 fold increase
in Ya+Yc messenger RNA contents was achieved. The size of the messenger RNAs
was around 900 nucleotides (Fig.4, Table 1). A dot blot analysis of the nuclear
pre-m-RNAs, 12hr after a single injection of phenobarbitone also revealed a pheno-
menal increase in the case of cytochrome P-450(b+e) and this increase was blocked
by the simultaneous administration of 3-amino-1,2,4-triazole or CoCI2. However,
none of the drug treatments either alone or in the combination significantly changed
the nuclear pre-mRNA contents for glutathione transferase (Ya+Yc) subunits (Fig.5).
A detailed analysis of the kinetics of induction of glutathione transferase
(Ya+Yc) subunit messenger RNAs and cytochrome P-450 (b+e) messenger RNAs
after a single injection of phenobarbitone was then undertaken. Nick-translated
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1 2 3 4 5 6 Fig.4. Northern blot analysis of poly (A)-
containing RNAs isolated from drug treated
rats. The RNA preparations (41j g) (described
in Fig.3) were subjected to Northern blot
analysis using nick-translated pGT 19.
Lane 1, control; Lane 2, 3-methylcholanthrene;
Lane 3, control (6,jg RNA); Lane 4, phenobarbi-
tone; Lane 5, 3-amino-1 ,2,4-triazole; Lane 6,
CoCI2 pBR 322 DNA cut with Hinf I was
used for size calibration.
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Fig.5. Dot blot analysis of nuclear RNA isolated from drug treated rats. Nuclear
RNAs were isolated 12 hr after the drug administration and ic1 g of each
preparation was analysed by dot blot hybridization using nick-translated
pGT 19 (A) and pP-450 91 (B). (1) control (2) phenobarbitone (3) 3-amino-1,2,-
4-triazole (4) CoCl2 In the case of cytochrome P-450 (b+e) studies, 3-amino-I,-
2,4-triazole and CoCl2were given along with phenobarbitone since their effects
were studied on the induction process. In the case of glutathione transferase
(Ya+Yc) studies, 3-amino-1,2,4-triazole and CoC12 were given in the absence
of phenobarbitone. Even in the presence of phenobarbitone, the results obtai-
ned were essentially the same.
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Fig.6. Time course of induction of cytochrome P-450 (b+e) and glutathione trans-
ferase (Ya+Yc) messenger RNAs. The specific messenger RNAs were quanti-
fied by hybridization of total poly (A)- containing RNAs (ljg) with nick-trans-
lated probes in dot blot experiments. The values given are an average of
two independent experiments. The other experimental details are given in
text. (0) Cytochrome P-450 (b+e) messenger RNA content after phenobarbi-
tone treatment; ( A) glutathione transferase (Ya+Yc) messenger RNA content
after phenobarbitone treatment.
pGT 19 and pP-450 91 were used as probes. It was found that the cytochrome P-450
(b+e) messenger RNAs increased sharply within 4hr, reached a 12-15 fold increase
around 16hr and then showed a rapid decline. Glutathione transferase (Ya+Yc)
subunit messenger RNAs showed a sluggish increase in comparison and reached
a maximum of 3-4 fold around 24hr after a single injection of the drug (Fig.6).
The kinetics of messenger RNA induction as well as the status of nuclear
pre-mRNAs are indicative of the transcription rates of the two gene systems.
To confirm this, run-off transcription rates with nuclei isolated from rats given
different drug treatments were assessed. The restilts presented in Table 2 indicate
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TABLE 2
Comparative rates of transcription of cytochrome P-450 (b+e) and glutathione
transferase (Ya+Yc) genes with isolated nuclei in vitro.
Cytochrome P-450 Glutathione transferase
Treatment (b+e) (Ya+Yc)
(ppm/Kb of cloned probe hybridised)
Control 7 48
Phenobarbitone (4 hr) 102 95
Phenobarbitone (12 hr) 91 58
Phenobarbitone +
CoC12 (4hr) 17
Phenobarbitone +
CoCI2 (12 hr) 21
Phenobarbitone +3-amino
1,2,4-triazole (4hr) 20
Phenobarbitone +3-amino
1,2,4-triazole (12hr) 25
CoCI2 (4hr) - 55
CoC12 (12hr) - 50
3-Amino-1,2,4-triazole (4hr) - 63
3-Amino-1,2,4-triazole (12hr) - 58
The in vitro transcription was carried out with isolated nuclei in the presence
of [a- 32p UTP as described in the text (26). Nuclei were isolated from control
and phenobarbitone treated rats. The in vitro transcripts (107 cpm) were hybridized
to pGT 19 or pP-450 91 DNA loaded on nitrocellulose filters. pBR 322 DNA was
used to compute non-specific hybridization, which was less than 10% of specific
hybridization. The results are expressed as ppm (parts per million) of the transcripts
hybridized per Kb of the cloned probe and represent the average from two different
experiments. The other details are given in text.
that 4hr after phenobarbitone administration there was nearly two-fold increase
in glutathione transferase (Ya+Yc) messenger RNA transcription rates. However,
with 3-amino-1,2,4-triazole and CoCI2 treatments the increase was only marginal.
At 12hr after the drug treatments, phenobarbitone treatment at best elicited only
about 30% increase in the glutathione transferase (Ya+Yc) messenger RNA transcrip-
tion rates, whereas 3-amino-1,2,4-triazole and CoCI2 treatments had no effect.
In contrast, phenobarbitone treatment elicited high levels of transcription rates
for cytochrome P-450 (b+e) messenger RNA at both time intervals and 3-amino
1,2,4-triazole and CoCI2 treatments substantially blocked this increase. None of
the treatments significantly affected the total transcription rates. Addition of
a-amanitin (1 pg/ml) inhibited total transcription by around 50%, but the transcrip-
tion of the two gene systems under consideration was inhibited by more than 95%
(data not presented).
Next, an attempt was made to measure the half-lives of cytochrome P-450
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Fig.7. Half-life measurements of cytochrome P-450 (b+e) and glutathione transferase
(Ya+Yc) messenger RNAs. Actinomycin D or cordycepin was administered
12 hr (cytochrome P-450 b+e) and 20 hr (glutathione transferase Ya+Yc)
after phenobarbitone administration to block fresh transcription and poly
(A)- containing RNAs isolated at different time intervals. The specific messen-
ger RNAs were quantified by dot blot hybridization with nick-translated
probes. The results represent the mean + S.D. obtained from three independ-
ent RNA preparations. A- Actinomycin D treatment. B- Cordycepin treat-
ment. (0)- cytochrome P-450 (b+e) messenger RNA content in phenobarbitone-
pretreated animals. ( A) Glutathione transferase (Ya+Yc) messenger RNA
content in phenobarbitone pretreated and (A) saline treated animals.
(b+e) and glutathione transferase (Ya+Yc) messenger RNAs. For this purpose, acti-
nomycin D or cordycepin was administered to control as well as phenobarbitone
pre-treated rats and the specific messenger RNA contents were quantified by hybri-
dization at different time intervals after the administration of the transcription
inhibitors. In preliminary experiments, it was found that actinomycin D and cordy-
cepin inhibited poly (A)-containing RNA synthesis by 95% and 80% respectively
and that the inhibition lasted for atleast 8hr (data not presented). Therefore, the
specific messenger RNA levels were quantified upto 8hr only. The results presented
in Fig. 7 indicate that with both inhibitors glutathione transferase (Ya+Yc) messen-
ger RNAs were found to have a half-life around 8-9hr and administration of pheno-
barbitone enhanced the half-life by 2-fold. In phenobarbitone treated rats, cyto-
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chrome P-450 (b+e)messenger RNAs were found to have a half-life around 3-4
hr. It was not possible to make half-life measurements in the control animal, in
view of the very low content of the cytochrome P-450 (b+e) messenger RNAs.
DISCUSSION
Foreign chemicals induce enzymes in and outside the drug metabolizing pat-
hway. The exact mechanism of this induction process has not been understood.
However, in the case of cytochrome P-450, a specific transcriptional activation
mechanism has been recognized (6-9). Strong evidences for the existence of a
receptor for hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methyl-
cholanthrene have been presented and the involvement of the inducer-receptor
complex in activating specific cytochrome P-450 genes has been suggested (28-30).
In that light, the mechanism of action of inducers on the other enzymes of the
drug metabolizing complex assumes importance, since it would raise questions
on the specificity and multiplicity of receptors for an inducer, if a transcriptional
activation mechanism is favoured in every case.
Phenobarbitone also induces specific cytochrome P-450 species by transcrip-
tional activation (6,7,9), although there is no definitive evidence for the mediation
of a receptor. However, it is interesting to point out that whereas phenobarbitone
and 3-methylcholanthrene induce distinctly different species of cytochrome P-450,
they appear to induce the same subunit species (Ya+Yc) of glutathione transferese.
In addition, inhibitors of cytochrome P-450 (b+e) messenger RNA synthesis such
as CoCd2 and 3-amino-1,2,4-triazole actually enhance the glutathione transferase
(Ya+Yc) messenger RNA levels.
The present studies reveal that while the dramatic increase in cytochrome
P-450 (b+e) messenger RNA levels in response to a single injection of phenobar-
bitone can be explained on the basis of sustained high transcription rates of the
genes concerned, the increase in glutathione transferase (Ya+Yc) messenger RNAs
cannot be explained on this basis. Phenobarbitone does increase glutathione trans-
ferase (Ya+Yc) transcription rates by nearly 2-fold at early time intervals, but
by 12hr the rates are only marginally higher than control, when the specific messen-
ger RNA levels continue to increase. In addition, CoCd2 and 3-amino-1,2,4-triazole
have only a marginal or no effect on transferase transcription rates, but neverthe-
less increase the specific messenger RNA contents.
Therefore, we have examined the possibility whether stabilization of gluta-
thione transferase messenger RNAs by drug treatments can explain the increase
in messenger RNA levels and enzyme protein content and activity. Measurement
of half lives of protein and nucleic acids after blocking fresh translation and trans-
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cription with suitable inhibitors is a standard procedure, although the possibility
of the inhibitors by themselves having an effect on the degradative process cannot
be ruled out (31,32). We have used actinomycin D, an inhibitor of transcription
and cordycepin, an RNA synthesis chain terminator to block fresh RNA synthe-
sis. Earlier, it has been shown that cordycepin blocks the phenobarbitone-mediated
messenger RNA induction for enzymes such epoxide hydratase, NADPH-cytochrome
P-450 reductase and cytochrome P-450b (33-35). On the basis that the transcription
inhibitors exert similar effects in control and drug-treated rats, the results indi-
cate that phenobarbitone administration enhances the half-life of glutathione trans-
ferase (Ya+Yc) messenger RNAs. Besides, the time course of induction of gluta-
thione transferase (Ya+Yc) messenger RNAs after phenobarbitone administration
(Fig.6) indicates that the messenger RNA half-life values obtained for the drug
treated animals by the use of the transcription inhibitors (Fig.7) are approximately
in the same range of values that can be calculated on the basis that the rate of
approach to the new steady state is directly related to the degradation rate constant
(36). However, it has been possible to make half-life measurements only upto 8hr,
since the transcription inhibitors were found to inhibit poly (A) - containing RNA
synthesis maximally only upto this time point. Besides, the half-life values are
a composite of two subunit messenger RNAs since the probes used hybridize to
both the messenger RNAs having extensive homologies. Despite these limitations,
the data clearly indicate stabilization as a major mechanism for the induction
of transferase messenger RNAs, whereas, the increase in cytochrome P-450 messen-
ger RNAs is essentially due to sustained high transcription rates. The list of messen-
ger RNAs known to. be regulated atleast in part by turnover control includes hen
ovalbumin, Xenopus vitellogenin, rat casein, dihydrofolate reductase and tubulin
(36). It is not clear whether the initial increase in the glutathione transferase trans-
cription after phenobarbitone administration 'triggers' a cascade of events. We
have, however, found that a wide variety of chemicals induce glutathione transferase
(Ya+Yc) subunits and perhaps a generalized second messenger type response rather
than an inducer-specific receptor mechanism is involved. It may also be pointed
out that glutathione transferase is a major cytosolic protein in the normal rat
liver unlike the induced cytochrome P-450 species which are present at very low
levels in the untreated animal. Therefore, the glutathione transferase gene is
perhaps transcribed at a high efficiency in the normal animal and the induction
process should rather involve stabilization mechanisms.
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